Prediction of ADME properties for drug discovery.

被引:0
|
作者
Egan, WJ [1 ]
Merz, KM [1 ]
机构
[1] Pharmacopeia Inc, Ctr Informat & Drug Discovery, Princeton, NJ 08543 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
44-COMP
引用
收藏
页码:U283 / U283
页数:1
相关论文
共 50 条
  • [21] Natural products in drug discovery.
    Danishefsky, SJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U364 - U365
  • [22] Genomics and CNS drug discovery.
    Paul, SM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 604 - 605
  • [23] Impact of biotechnology on drug discovery.
    Drews, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U168 - U168
  • [24] Impact of pharmacogenomics on drug discovery.
    Lichter, JB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1191 - U1192
  • [25] Using mass spectrometry to determine ADME properties in drug discovery
    Unger, SE
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 307 - 316
  • [26] Role of contemporary drug metabolism in drug discovery.
    Baillie, TA
    CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (12) : 1969 - 1969
  • [27] Redox signaling for cancer drug discovery.
    Powis, G
    CLINICAL CANCER RESEARCH, 1999, 5 : 3879S - 3879S
  • [28] The personalized medicine strategy in drug discovery.
    Ginsburg, GS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U472 - U472
  • [29] Encoded combinatorial libraries in drug discovery.
    Guo, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U127 - U127
  • [30] Genetic approaches to cancer drug discovery.
    Dunstan, HM
    Szankasi, P
    Lamb, JL
    Simon, JA
    Hartwell, LH
    Friend, SH
    CLINICAL CANCER RESEARCH, 1999, 5 : 3776S - 3776S